Symposium III
Chronic Infections

Programme

• 16:00 – 16:35 30 Min. 5 Min.

  • Key-Note-Lecture
  • S-3-1

  Monitoring and targeting cccDNA for HBV cure

  • Dr. Barbara Testoni (Lyon/ FR)
• 16:35 – 16:50 10 Min. 5 Min.

  • Highlight-Vortrag
  • S-3-2

  Five years follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D

  • Prof. Dr. Heiner Wedemeyer (Hannover/ DE)

   Chronic Infections
• 16:50 – 17:00 8 Min. 2 Min.

  • Short Talk
  • S-3-3

  CD8⁺ T cells recognize CagA-derived epitopes and mediate pathogen control in Helicobacter pylori infection

  • Maximilian R. A. Koch (Munich/ DE)

   Chronic Infections
• 17:00 – 17:10 8 Min. 2 Min.

  • Short Talk
  • S-3-4

  MALDI imaging analysis in combination with an advanced mouse model reveals that clinical-stage drug BTZ‑043 accumulates in tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis

  • Dr. Kerstin Walter (Borstel/ DE)

   Chronic Infections
• 17:10 – 17:20 8 Min. 2 Min.

  • Academy Talk
  • S-3-5

  A novel class of glycan-sensitive human monoclonal antibodies neutralising the hepatitis E virus

  • Katja Dinkelborg (Hannover/ DE)

   Chronic Infections
• 17:20 – 17:30 8 Min. 2 Min.

  • Short Talk
  • S-3-6

  Automated high-throughput screen discovers members of the Akt serine/threonine kinase family as targets for treatment of HEV virus infection

  • Mara Klöhn (Bochum/ DE)

   Chronic Infections